Invicta Diagnostic Limited (NSE:INVICTA)

India flag India · Delayed Price · Currency is INR
62.00
-3.45 (-5.27%)
At close: Mar 9, 2026
Market Cap 779.46M
Revenue (ttm) 301.81M
Net Income (ttm) 48.92M
Shares Out 12.57M
EPS (ttm) 5.81
PE Ratio 10.67
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,400
Average Volume 34,720
Open 66.50
Previous Close 65.45
Day's Range 62.00 - 66.50
52-Week Range 58.10 - 105.00
Beta n/a
RSI 43.70
Earnings Date Mar 2, 2026

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo... [Read more]

Industry Medical Laboratories
Founded 2016
Employees 113
Stock Exchange National Stock Exchange of India
Ticker Symbol INVICTA
Full Company Profile

Financial Performance

In fiscal year 2025, Invicta Diagnostic's revenue was 301.81 million, an increase of 89.84% compared to the previous year's 158.98 million. Earnings were 48.92 million, an increase of 30.04%.

Financial Statements

News

There is no news available yet.